Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesPediatrics/Neonatologyselect_health Donor human milk Coverage | OpenPaye…
    Ask Trek AI about this page
    Currentselect_healthPolicy CCP.1185

    Donor human milk

    Customize your policy alerts

    Sign up for select_health Policy CCP.1185 alerts

    Get alerted when Policy CCP.1185 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage policy for pasteurized donor human milk for infants, focused on high-risk neonates when mother's own milk is unavailable or contraindicated; intended for Select Health of South Carolina coverage determinations.

    Policy Summary
    Payerselect_health
    PolicyDonor human milk
    Policy CodePolicy CCP.1185
    Change TypeRevised (evidence-informed reorganized criteria)
    Effective DateNov 20, 2025
    Last ReviewNov 1, 2025
    Next Review DateMar 1, 2027
    Key ActionObtain prior authorization confirming infant ≤6 months, mother's milk is contraindicated or unavailable despite lactation support, and at least one qualifying clinical indication (e.g., VLBW ≤1,500 g or GA ≤32 weeks).
    SourceLink
    POLICY UPDATE CHANGES

    Findings were reorganized thematically and coverage criteria were revised based on systematic reviews, meta-analyses, and international and national guidelines.

    An additional guideline from the Canadian Paediatric Society (2022) was added to the evidence base.

    ≤1,500 g / ≤32 wkVLBW/GA threshold
    ≤6 moAge cutoff
    12 RCTsCochrane evidence

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    None identified
    Policy limitations

    Coverage Criteria for Donor Human Milk

    Medical necessity criteria

    Covered when ALL of the following are met

    Primary eligibility: Infant is 6 months of age or younger<=6 months
    Maternal milk status: Mother's own milk is contraindicated or unavailable despite lactation support

    Lactation specialist services should be offered within the network as an alternative or adjunct prior to or concurrent with donor human milk when mother's milk may be insufficient

    Clinical indication

    • VLBW or preterm: Risk for necrotizing enterocolitis defined by very low birth weight (<=1,500 g) OR gestational age <=32 weeksBirth weight <=1,500 g or gestational age <=32 weeks
    • Malabsorption conditions: Condition causing impaired nutrient absorption (examples include gastrointestinal anomalies, metabolic or digestive disorders, recovery from intestinal surgery, short bowel syndrome, or exocrine pancreatic insufficiency)
    Safe sourcing: Donor human milk is obtained from regulated milk banks that perform donor screening, pasteurization, and validated handling protocols when available

    Informal milk sharing is discouraged due to infectious and chemical contamination risks

    Routine use of pasteurized donor human milk is not supported for infants outside the high‑risk neonatal groups described in this policy. The evidence base converges on clinical benefit for preterm and very low birth weight infants when mother's own milk is unavailable, but for healthy moderate‑late preterm or term infants the studies are limited and do not demonstrate routine advantage; therefore routine provision for these populations is not routinely covered. Safety considerations also limit use when milk is obtained outside regulated milk banking systems.

    Evidence for donor human milk in populations outside very preterm or very low birth weight infants is limited and heterogeneous. High‑quality systematic reviews and randomized trials consistently show a prevention signal for necrotizing enterocolitis in VLBW/preterm infants, but reviews of moderate‑late preterm and early‑term healthy infants report no clear benefit for supplementation with donor human milk versus formula and note small, inconsistent samples and endpoints. These uncertainties mean clinical benefit is not well established for non‑high‑risk groups.

    Coding and Key Thresholds

    No specific codes listedmixed
    No codes listed
    VLBW/GA threshold for NEC risk
    VLBW/GA thresholdBirth weight ≤1,500 g OR gestational age ≤32 weeks
    Primary NEC risk cutoffVery low birth weight defined as ≤1,500 g
    Alternative GA criterionGestational age ≤32 weeks
    Age cutoff
    Age cutoff for coverage considerationInfant is 6 months of age or younger
    Timing rationaleMatches recommendations prioritizing exclusive breastfeeding for first six months
    Authorization relevance

    Provider Requirements and Authorization

    Prior Authorization

    Obtain prior authorization confirming eligibility and safe milk sourcing

    Donor human milk requires prior authorization. Confirm the infant is 6 months of age or younger, the mother's own milk is contraindicated or unavailable despite lactation support, and at least one qualifying clinical indication is present (for example: very low birth weight ≤1,500 g or gestational age ≤32 weeks, or a malabsorption condition). The authorization should also verify that milk is sourced from regulated milk banks when available.

    • Infant ≤6 months of age
    • Mother's own milk contraindicated or unavailable despite lactation support
    • At least one clinical indication (e.g., VLBW ≤1,500 g or GA ≤32 weeks, or malabsorption)
    • Source from regulated milk banks preferred
    Step Therapy

    Offer in‑network lactation specialist services before or with donor milk requests

    Offer access to lactation specialist services within the network prior to or concurrent with consideration of donor human milk to support maternal milk production and assess availability of mother's own milk.

    Background and Rationale

    Exclusive breastfeeding is recommended for the first six months because human milk provides important enzymes and immune protection for infants. Very preterm and very low birth weight infants are at higher risk for feeding difficulties and for necrotizing enterocolitis (NEC); multiple systematic reviews and randomized trials show that pasteurized donor human milk, when mother's milk is unavailable or contraindicated, reduces the risk of NEC relative to formula, although it may be associated with slower short‑term in‑hospital growth unless fortified. The safety and clinical utility of donor human milk depend on sourcing through regulated milk banks that perform donor screening, pasteurization, and validated handling protocols.

    Definitions

    Very low birth weight (VLBW) definition
    VLBW definitionVery low birth weight (VLBW) = infant birth weight ≤1,500 grams
    Clinical importanceVLBW infants are at higher risk for feeding difficulties, infection, and long‑term health problems
    Policy roleVLBW (≤1,500 g) is a qualifying clinical indication for donor human milk coverage
    Necrotizing enterocolitis (NEC)
    NEC — core definitionNecrotizing enterocolitis (NEC) is a severe gastrointestinal condition primarily affecting preterm infants, involving necrosis of the digestive tract and potentially requiring surgery or prolonged NICU care
    NEC and donor milk evidenceHigh‑certainty evidence (2024 Cochrane review, 12 RCTs, N=2,296) shows donor human milk reduces NEC incidence by about one‑half compared with formula
    Policy Summary
    Payerselect_health
    PolicyDonor human milk
    Policy CodePolicy CCP.1185
    Change TypeRevised (evidence-informed reorganized criteria)
    Effective DateNov 20, 2025
    Last ReviewNov 1, 2025
    Next Review DateMar 1, 2027
    Key ActionObtain prior authorization confirming infant ≤6 months, mother's milk is contraindicated or unavailable despite lactation support, and at least one qualifying clinical indication (e.g., VLBW ≤1,500 g or GA ≤32 weeks).
    SourceLink
    On This Page
    Coverage Criteria for Donor Human MilkCoding and Key ThresholdsProvider Requirements and AuthorizationBackground and RationaleDefinitions
    Must be documented to support medical necessity and prior authorization
    • Provide in-network lactation specialist consultation before or during prior authorization process
    • Document attempts at lactation support to show mother's milk is unavailable or contraindicated
    Documentation Required

    Required documentation to support medical necessity

    Document the clinical information needed to establish medical necessity: infant age (≤6 months), evidence that mother's own milk is contraindicated or unavailable despite lactation support, and at least one qualifying clinical indication; when possible, document that donor milk is from a regulated milk bank that uses screening and pasteurization.

    • Infant date of birth or age confirming ≤6 months
    • Clinical notes showing mother's milk contraindication or unsuccessful lactation support efforts
    • Clinical diagnosis supporting indication (e.g., birth weight ≤1,500 g, gestational age ≤32 weeks, or specified malabsorption condition)
    • Source documentation showing regulated milk banking/pasteurization when available
    Denial Risk

    Coverage may be denied if clinical criteria are unmet

    Requests that do not meet the policy criteria risk denial. Coverage is limited to infants ≤6 months, when mother's milk is contraindicated or unavailable despite lactation support, and when at least one qualifying clinical indication is present.

    • Infant older than 6 months
    • Mother's own milk available or not shown to be contraindicated after lactation support
    • No qualifying clinical indication (e.g., neither VLBW ≤1,500 g nor GA ≤32 weeks nor documented malabsorption)
    Clinical impactNEC can lead to surgery, lengthy NICU stays, death, and multiple comorbidities—hence prevention via human milk is clinically significant
    Regulated milk banking
    Regulated milk banking definitionMilk obtained from milk banks that perform rigorous donor screening, pasteurization, and validated handling protocols
    Safety rationaleNational guidance advises milk from regulated banks to avoid infectious and chemical contamination associated with informal sharing
    Implementation noteAvailability of regulated milk banking is concentrated in high‑resource settings and may limit access